Crystal structures of (S)-3-hydroxybutyryl-CoA dehydrogenase from Clostridium acetobutylicum have been determined in apo and NAD+-bound forms. The structures, together with kinetic analyses using single-amino-acid substituted mutants, revealed the catalytically important residues in the enzyme.
Keywords: bio-based plastics, enzyme kinetics, fatty-acid metabolism, SDR superfamily, X-ray protein crystallography
Abstract
(S)-3-Hydroxybutyryl-CoA dehydrogenase (HBD) has been gaining increased attention recently as it is a key enzyme in the enantiomeric formation of (S)-3-hydroxybutyryl-CoA [(S)-3HB-CoA]. It converts acetoacetyl-CoA to (S)-3HB-CoA in the synthetic metabolic pathway. (S)-3HB-CoA is further modified to form (S)-3-hydroxybutyrate, which is a source of biodegradable polymers. During the course of a study to develop biodegradable polymers, attempts were made to determine the crystal structure of HBD from Clostridium acetobutylicum (CacHBD), and the crystal structures of both apo and NAD+-bound forms of CacHBD were determined. The crystals belonged to different space groups: P212121 and P21. However, both structures adopted a hexamer composed of three dimers in the asymmetric unit, and this oligomerization was additionally confirmed by gel-filtration column chromatography. Furthermore, to investigate the catalytic residues of CacHBD, the enzymatic activities of the wild type and of three single-amino-acid mutants were analyzed, in which the Ser, His and Asn residues that are conserved in the HBDs from C. acetobutylicum, C. butyricum and Ralstonia eutropha, as well as in the l-3-hydroxyacyl-CoA dehydrogenases from Homo sapiens and Escherichia coli, were substituted by alanines. The S117A and N188A mutants abolished the activity, while the H138A mutant showed a slightly lower K m value and a significantly lower k cat value than the wild type. Therefore, in combination with the crystal structures, it was shown that His138 is involved in catalysis and that Ser117 and Asn188 may be important for substrate recognition to place the keto group of the substrate in the correct position for reaction.
1. Introduction
Recently, emphasis on the use of environmentally friendly products has focused on the development of biodegradable polymers to replace nondegradable polymers that build up in soil and water. Biodegradable polymers have been synthesized in bacteria using metabolic pathway engineering (Hiraishi & Taguchi, 2009 ▸; Matsumoto & Taguchi, 2013 ▸). Such efforts will decrease the dependence on fossil fuel resources to produce plastics. Additionally, biodegradable polymers from sustainable materials such as corn, cane sugar, potato starch and tapioca starch can be made into polyesters and eventually recycled into soil (Shen et al., 2010 ▸).
Several bio-based plastics have been produced utilizing renewable feedstocks. For example, homopolymers of lactate (LA) and 3-hydroxybutyrate (3HB) can be synthesized via a chemical/biological process and microbial fermentation, respectively. In the cases of the copolymers of LA and 3HB, the physical properties of the bioplastics can be varied by regulating the monomer composition and molecular weight in response to the desired applications (Taguchi et al., 2008 ▸; Yamada et al., 2010 ▸). For 3HB, which has enantiomeric isomers, only the R-form has been utilized. 3HB is synthesized in vivo starting from acetyl-CoA via two sequential enzymatic reactions. Two molecules of acetyl-CoA are first condensed to generate acetoacetyl-CoA by β-ketothiolase (PhaA). Acetoacetyl-CoA is then reduced to either (R)-3HB-CoA by an NADPH-dependent acetoacetyl-CoA reductase (PhaB) or to (S)-3HB-CoA by (S)-3-HB dehydrogenase (HBD). These compounds are stereoselectively converted to (R)-3HB and (S)-3HB, respectively, in living cells.
The development of an efficient monomer- and oligomer-production system in Escherichia coli using PhaB, which specifically synthesizes (R)-3HB-CoA, has been achieved (Oeding & Schlegel, 1973 ▸; Senior & Dawes, 1973 ▸; Kawaguchi & Doi, 1992 ▸; Matsumoto, Okei et al., 2013 ▸). Furthermore, engineering of PhaB has successfully been achieved based on the tertiary structure of PhaB from Ralstonia eutropha (Matsumoto, Tanaka et al., 2013 ▸). On the other hand, specific synthesis of (S)-3HB-CoA is not as commonly used as that of the CoA precursor of (R)-3HB, which is incorporated into the polymeric backbone (Boynton et al., 1996 ▸; Lee et al., 2008 ▸; Tseng et al., 2009 ▸). Since (S)-3HB is useful as a building block for bioactive compounds such as antibiotics, the bioproduction of (S)-3HB has been extensively carried out in E. coli by the combination of HBD with a CoA-removing enzyme. In this context, we have focused on the HBD protein from Clostridium acetobutylicum (CacHBD) throughout our study of monomer production of (S)-3HB. In this paper, we report the crystal structures of apo CacHBD and the NAD+-bound form of CacHBD, which exhibited a hexameric form that differs from those of the HBDs from R. eutropha and C. butyricum, the latter of which is highly homologous to CacHBD. A kinetic study also demonstrated the roles of catalytically important residues using single-amino-acid substituted mutants.
2. Materials and methods
2.1. Cloning, expression and purification of CacHBD
The gene encoding (S)-3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) from C. acetobutylicum ATCC 824 (Cachdb; 843 bp) was amplified by polymerase chain reaction (PCR) using the synthesized Cachbd gene with codon optimization for E. coli as a template. The PCR product was cloned into pET-28b(+) (Novagen) with an N-terminal 6×His tag using NdeI and XhoI restriction enzymes. Consequently, the extra sequence MGSSHHHHHHSSGLVPRGSH was added to the N-terminus of the recombinant enzyme. This expression plasmid was transformed into the Rosetta 2(DE3) E. coli strain. To prepare the single amino-acid mutants (S117A, H138A and N188A), the pET28b-Cachbd plasmid was used as a template. The following primers were used to introduce point mutations into pET-28b-Cachbd by PCR: 5′-ACCGCGTCTCTGTCTATCACC-3′ and 5′-AGAGACGCGGTGTTAGACGC-3′ were used for S117A, 5′-TATGGCGTTCTTCAACCCGGCGCCG-3′ and 5′-AGAACGCCATACCGATAACTTTGTC-3′ were used for H138A and 5′-TTGCGCGTATCCTGATCCCGATGATC-3′ and 5′-ATACGCGCAACAACGAAACCCGGCG-3′ were used for N188A. Each mutation that was introduced was confirmed by sequencing.
E. coli cells harboring the expression plasmid were cultured in Luria–Bertani (LB) broth medium containing 25 µg ml−1 kanamycin and 34 µg ml−1 chloramphenicol at 20°C. After 8 h of culture, 250 µM (final concentration) isopropyl β-d-1-thiogalactopyranoside (IPTG) was added for induction of the target protein. The culture was then continued for 16 h and the cells were harvested by centrifugation at 4648g for 15 min at 4°C.
The cells were resuspended in buffer consisting of 20 mM Tris–HCl pH 7.5, 20 mM imidazole, 200 mM NaCl and were homogenized by ultrasonication. The supernatant that was separated by centrifugation at 69 673g for 40 min was purified using an Ni cOmplete column (Roche) and an anion-exchange Mono Q column (GE Healthcare Bio). The purified CacHBD was then concentrated to 30 mg ml−1 by ultrafiltration with Amicon Ultra (Millipore).
2.2. Crystallization
Crystallization was performed using the hanging-drop vapor-diffusion method at 20°C for both apo and NAD+-bound CacHBD. In the case of NAD+-bound CacHBD, a final concentration of 5 mM NAD+ was added to 30 mg ml−1 protein solution. The protein solution and reservoir solution were mixed in a 1:1 ratio. After optimization of the reservoir condition, NAD+-bound crystals grew to dimensions of 0.4 × 0.1 × 0.1 mm using a reservoir solution consisting of 17.5% PEG 3350, 200 mM sodium thiocyanate. Apo crystals grew to dimensions of 0.4 × 0.2 × 0.2 mm using a reservoir solution consisting of 1.25% PEG 400, 2.2 M ammonium sulfate, 0.1 M HEPES–NaOH pH 7.5.
2.3. Data collection and structure determination
Crystals were flash-cooled in liquid nitrogen using nylon loops without a cryoprotectant solution. Diffraction data were collected on beamlines BL-17A and AR BL-NE3 at the Photon Factory (PF), Tsukuba, Japan. Indexing, integration, scaling and merging were carried out using HKL-2000 (Otwinowski & Minor, 1997 ▸).
The initial structure of NAD+-bound CacHBD was determined by the molecular-replacement method using MOLREP (Vagin & Teplyakov, 2010 ▸). The structure of HBD from C. butyricum (CbuHBD; PDB entry 4r1n; Kim, Kim et al., 2014 ▸) served as a search model since the sequence identity of HBD between C. acetobutylicum and C. butyricum is 81.2%. The model was then constructed using ARP/wARP (Langer et al., 2008 ▸). Further iterative refinement and model building were conducted with REFMAC5 (Murshudov et al., 2011 ▸) and Coot (Emsley et al., 2010 ▸), respectively. All programs apart from HKL-2000 and Coot were used within the CCP4 suite (Winn et al., 2011 ▸). The structure of apo CacHBD was determined by molecular replacement using the NAD+-bound structure as a search model. Data-collection and refinement statistics are summarized in Table 1 ▸.
Table 1. Data-collection and refinement statistics.
Apo | NAD+ complex | |
---|---|---|
Data collection | ||
Beamline | AR BL-NE3, PF | BL-17A, PF |
Wavelength (Å) | 1.000 | 0.980 |
Space group | P212121 | P21 |
Unit-cell parameters (Å, °) | a = 133.4, b = 134.5, c = 153.8 | a = 77.4, b = 157.9, c = 81.8, α = 90.0, β = 100.9, γ = 90.0 |
Resolution range (Å) | 50.0–2.50 (2.54–2.50) | 50.0–2.10 (2.14–2.10) |
Completeness (%) | 100 (100) | 98.6 (99.0) |
〈I/σ(I)〉 | 19.9 (1.9) | 14.1 (2.0) |
Multiplicity | 6.7 (6.6) | 2.2 (2.2) |
R merge † (%) | 9.4 (68.5) | 4.9 (31.6) |
No. of unique reflections | 95544 | 109647 |
Refinement | ||
Resolution range (Å) | 47.9–2.50 (2.54–2.50) | 48.46–2.10 (2.14–2.10) |
No. of reflections | 90674 | 104116 |
R/R free ‡ (%) | 19.9/22.2 | 19.2/22.4 |
No. of atoms | ||
Protein | 12912 | 12749 |
Solvent | 79 | 404 |
Ligand (NAD+) | — | 88 |
R.m.s.d. from ideality | ||
Bond lengths (Å) | 0.010 | 0.009 |
Bond angles (°) | 1.326 | 1.308 |
Average B factor (Å2) | ||
Protein | 57.4 | 36.78 |
Solvent | 40.4 | 31.7 |
Ligand (NAD+) | — | 49.4 |
R merge = , where I i(hkl) is the ith measurement.
A subset of the data (5%) was excluded from refinement and used to calculate R free.
2.4. Gel-filtration chromatography
A Superdex 200 Increase 10/300 GL column (GE Healthcare Bio) was used to calculate the molecular weight of CacHBD in solution. The column was equilibrated with buffer consisting of 50 mM HEPES–NaOH pH 7.5, 150 mM NaCl. Ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa) and ovalbumin (43 kDa) from Gel Filtration Calibration Kit HMW (GE Healthcare Bio) were used as molecular markers.
2.5. Enzyme assay
The enzymatic activity of CacHBD was measured by the oxidation of NADH to NAD+ and was monitored by spectroscopy at 340 nm using a V-750ST spectrophotometer (Jasco) equipped with a CTU-100 circulating thermostat unit (Jasco). The total volume of the reaction mixture was 1 ml; it contained 0.1 M HEPES–NaOH pH 7.5 and 200 µM NADH to determine the kinetic parameters of acetoacetyl-CoA or 50 µM acetoacetyl-CoA instead of NADH to determine the kinetic parameters of NADH. The reaction buffer was pre-incubated for 2 min at 37°C, followed by serial additions of NADH, 10 nM (wild type) or 1 µM (mutants) CacHBD and acetoacetyl-CoA to initiate the reaction. Acetoacetyl-CoA at 10, 20, 30, 40, 50 and 100 µM, and NADH at 10, 20, 50, 100, 150 and 200 µM were used to determine the kinetic parameters. Each reaction was performed in triplicate. The data were confirmed to fit to the Michaelis–Menten equation and the parameters were calculated using a Lineweaver–Burk plot.
3. Results and discussion
3.1. Overall structure
The crystal structures of the apo and NAD+-bound forms of CacHBD were determined at 2.5 and 2.1 Å resolution, respectively. As expected, the overall structures of CacHBD and CbuHBD were essentially identical. When the monomer subunits of apo CacHBD and apo CbuHBD were superposed, the r.m.s.d. value (calculated for Cα atoms) was 0.73 Å, as calculated by Chimera (Pettersen et al., 2004 ▸). The monomer structure consisted of two domains. The N-terminal domain consisted of a Rossmann fold, which binds to NAD+ (Fig. 1 ▸ a), and the C-terminal domain formed a dimer interface in the crystal structure (Fig. 1 ▸ b). The apo and NAD+-bound CacHBD crystals belonged to space groups P212121 and P21, respectively. In the asymmetric unit, both crystals contained three dimers of CacHBD forming a hexamer, which belonged to point-group symmetry D3 with a pseudo-threefold axis and three twofold axes (Fig. 1 ▸ c). On the other hand, the CbuHBD crystal belonged to space group H3, and two and four dimers were present in the asymmetric unit for the apo (PDB entry 4r1n) and substrate-bound forms (PDB entry 4kuh), respectively. Space group H3 also has threefold symmetry, and we confirmed that the CbuHBD structures are also able to form the same hexamer as in CacHBD in the unit cell. However, CbuHBD was reported to form a dimer in a gel-filtration experiment (Kim, Kim et al., 2014 ▸). Therefore, we analyzed the oligomerization state of CacHBD in solution using gel-filtration column chromatography, which revealed that the calculated state was a 7.3-mer (Supplementary Fig. S1). It is therefore highly possible that CacHBD forms a hexamer in solution. The differences in buffer conditions between the experiments could have affected the oligomerization state; however, the cause of the difference in the oligomerization states could not be confirmed as the buffer conditions were not mentioned by Kim, Kim et al. (2014 ▸).
3.2. Comparison of monomer subunits of hexameric CacHBD
The crystal structures obtained in this study were composed of two types of dimers: a homodimer of two apo subunits and a heterodimer of NAD+-bound and apo subunits. No homodimers of NAD+-bound subunits were obtained. Therefore, three types of subunits existed: an apo subunit (type A) from a homodimer and an NAD+-bound subunit (type B) and an apo subunit (type C) from a heterodimer. When the C-terminal domains of the 12 monomers of apo and NAD+-bound CacHBD in the asymmetric units were superposed, they were essentially identical (Fig. 2 ▸ a, middle). However, one difference was observed for Glu90 in loop 1 containing Ala87–Arg91, as shown in Fig. 2 ▸(a). The side chains of Glu90 were flipped in two of the 12 monomers. These two subunits were type C. Among the 12 subunits in a hexamer, only two subunits bound to NAD+, and their counterpart subunits in the dimers did not bind to NAD+. The difference was caused by the mode of interaction of Glu90. In type A, Glu90 interacted with Thr116 and Ser118, forming hydrogen bonds with distances of 2.6 and 2.7 Å, respectively (Fig. 2 ▸ b, left). Glu90 in type B also formed hydrogen bonds to Thr116, Ser117, Ser118 and NAD+ at distances of 2.5, 3.0, 2.9 and 2.7 Å, respectively (Fig. 2 ▸ b, middle). On the other hand, type C subunits made no apparent interactions with other residues (Fig. 2 ▸ b, right).
Furthermore, we examined the temperature factors of loop 1 (consisting of Ala87–Arg91) and loop 2 (consisting of Asn115–Ser120). When loop 1 interacted with loop 2 in type A subunits, the temperature factors of loops 1 and 2 had high and low values, respectively (Fig. 2 ▸ c, left). In type B subunits, the temperature factors of both loops were lower (Fig. 2 ▸ c, middle). In type C subunits, which exhibited no interactions between loop 1 and loop 2, the temperature factors of both loops were higher (Fig. 2 ▸ c, right). Although the corresponding Glu residues are located at the nonflipped position in the case of the crystal structures of CbuHBD, the results suggest that loop 1 retains the flexibility to accept NAD+. Upon the binding of NAD+, loop 1 becomes more stable than that in apo CacHBD.
3.3. Comparison of monomer subunits between CacHBD and l-3-hydroxyacyl-CoA dehydrogenase from Homo sapiens
l-3-Hydroxyacyl-CoA dehydrogenase from H. sapiens (HuHAD) has acetoacetyl-CoA reductase activity (Barycki et al., 1999 ▸), and the crystal structure was determined as a ternary complex with NAD+ and acetoacetyl-CoA (PDB entry 1f0y; Barycki et al., 2000 ▸). Furthermore, crystal structures of HuHAD in the apo form (PDB entry 1f14) and in a binary form with NADH (PDB entry 1f17) have been determined (Barycki et al., 2000 ▸). These three crystal structures of HuHAD and the apo and NAD+-bound CacHBD structures were superposed. A significant difference was observed between apo CacHBD and the ternary complex of HuHAD. The other structures were similar to that of apo CacHBD. In this study, the N-terminal domains of the ternary complex of HuHAD and apo CacHBD were superposed using Chimera (Fig. 3 ▸). The r.m.s.d. value (calculated for Cα atoms) of the N-terminal domain was 0.77 Å (residues 1–188 in the N-terminus of CacHBD and residues 15–208 in the N-terminus of HuHAD). In this case, the r.m.s.d. value of the C-terminal domains was 7.50 Å over 93 residues (residues 189–281 in the C-terminus of CacHBD and residues 209–301 in the C-terminus of HuHAD). Since the N- and C-terminal domains of the ternary complex of HuHAD adopted a closed conformation compared with those of apo CacHBD, the distances between the N-terminal and C-terminal domains were measured using the amino acids located at the corresponding positions in the crystal structures. The distance between Thr11 in the N-terminal domain and Lys272 in the C-terminal domain of apo CacHBD was 14.2 Å. Meanwhile, in the ternary complex of HuHAD the distance between Leu25 in the N-terminal domain and Lys293 in the C-terminal domain was 8.0 Å (Fig. 3 ▸). A large domain movement therefore seemed to be induced upon the binding of acetoacetyl-CoA rather than upon that of NAD+.
3.4. The NAD+-binding site of CacHBD
In the CacHBD structure from the P21 crystal, only two subunits in the hexamer were observed to bind to NAD+. In the binding mode for NAD+, Thr11, Met12, Arg30, Asp31, Arg39, Glu90, Lys95, Asn115 and Ser117 formed hydrogen bonds to NAD+ in both or either of the subunits. On the other hand, the same residues as in CacHBD, except for Arg39, are involved in hydrogen bonds in CbuHBD (PDB entry 4kug; Kim, Kim et al., 2014 ▸). When the crystal structures were superposed using Chimera, they fitted well with an r.m.s.d. value of 0.88 Å (calculated on Cα atoms), and the binding modes for NAD+ in both proteins were almost identical, with a slight difference in the directions of the side chains of the amino-acid residues (Fig. 4 ▸). These differences may reflect the flexibility of the side chains of the residues and/or the differences in the resolutions of the crystal structures: 2.3 and 2.1 Å for CbuHBD and CacHBD, respectively. In addition to the hydrogen bonds formed, the adenine moiety of NAD+ was positioned in a hydrophobic pocket formed by Leu7, Ile32, Ala88, Val89, Ile94 and Ile98 in CacHBD. This pocket was also observed in CbuHBD (Kim, Kim et al., 2014 ▸), with a single difference of Val89 in CacHBD compared with Ile89 in CbuHBD.
3.5. Enzymatic activity
To characterize the properties of CacHBD, a kinetic analysis was performed with acetoacetyl-CoA as a substrate. The resulting K m values for acetoacetyl-CoA and NADH were 22.7 and 31.4 µM, respectively. The k cat values for acetoacetyl-CoA and NADH were 1.3 × 104 and 8.5 × 103 s−1, respectively (Table 2 ▸). These values were most comparable to those of HBD from R. eutropha (PaaH), with a K m of 18.5 µM and a k cat of 4.55 × 105 s−1 for acetoacetyl-CoA. The values for CbuHBD are a K m of 28 µM and a k cat of 3.4 × 103 min−1 for the substrate. The difference in the k cat values between CbuHBD and CacHBD may have resulted from the varying temperatures of the reactions (37 and 30°C for CacHBD and CbuHBD, respectively).
Table 2. Kinetic parameters for HBD from C. acetobutylicum .
NADH | Acetoacetyl-CoA | |||||
---|---|---|---|---|---|---|
CacHBD | K m (µM) | k cat (s−1) | k cat/K m (µM s−1) | K m (µM) | k cat (s−1) | k cat/K m (µM s−1) |
Wild type | 31.4 ± 4.9 | 8.5 × 103 ± 9.3 × 102 | 2.7 × 102 ± 1.2 × 10 | 22.7 ± 4.6 | 1.3 × 104 ± 1.1 × 103 | 6.3 × 102 ± 8.0 × 10 |
S117A | ND | ND | ND | ND | ND | ND |
H138A | 16.8 ± 1.2 | 93.8 ± 1.9 | 5.6 ± 0.3 | 9.6 ± 0.9 | 104.3 ± 2.2 | 11.0 ± 0.7 |
N188A | ND | ND | ND | ND | ND | ND |
The residues involved in the catalytic activities were investigated. With regard to l-3-hydroxyacyl-CoA dehydrogenase from E. coli (EcHAD), based on the sequence alignment, a single-amino-acid mutation of His450 corresponding to His138 in CacHBD (Fig. 5 ▸ a), which was substituted by alanine, dramatically decreased the k cat value with acetoacetyl-CoA as a substrate without changing the K m value (He & Yang, 1996 ▸). Barycki and coworkers reported the ternary-complex structure of human l-3-hydroxyacyl-CoA dehydrogenase with acetoacetyl-CoA and NAD+ and proposed that Ser149 (corresponding to Ser117 in CacHBD), His170 (His138) and Asn220 (Asn188) may be important for catalytic activity (Barycki et al., 2000 ▸). Kim, Chang et al. (2014 ▸) followed up these facts by introducing single-amino-acid substitutions of Ser119 (corresponding to Ser117 in CacHBD) and Asn190 (Asn188) by alanines in HBD from R. eutropha. The activities relative to the wild type were measured and exhibited a significant decrease (Kim, Chang et al., 2014 ▸). Therefore, in order to compare the activities and confirm the roles of these residues in CacHBD, we introduced single-amino-acid substitutions of Ser117, His138 and Asn188 by alanines. The H138A mutant showed a marked decrease in the k cat value but not the K m value, indicating a role in catalysis. Meanwhile, the k cat and K m values could not be calculated for the S117A and N188A mutants owing to very low activities. These two residues may therefore be important for substrate binding, especially in placing the keto group in the correct position for reaction (Fig. 5 ▸ b). In turn, this might reflect the fact that kinetic values for NADH were also not obtained.
Supplementary Material
Supplementary Figure S1.. DOI: 10.1107/S2053230X18014814/tb5129sup1.pdf
Acknowledgments
We thank Dr Ken’ichiro Matsumoto for providing us with a synthetic gene for CacHBD and for critical reading of the manuscript. We also thank the staff of the Photon Factory for assistance during data collection.
References
- Barycki, J. J., O’Brien, L. K., Bratt, J. M., Zhang, R., Sanishvili, R., Strauss, A. W. & Banaszak, L. J. (1999). Biochemistry, 38, 5786–5798. [DOI] [PubMed]
- Barycki, J. J., O’Brien, L. K., Strauss, A. W. & Banaszak, L. J. (2000). J. Biol. Chem. 35, 27186–27196. [DOI] [PubMed]
- Boynton, Z. L., Bennet, G. N. & Rudolph, F. B. (1996). J. Bacteriol. 178, 3015–3024. [DOI] [PMC free article] [PubMed]
- Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. [DOI] [PMC free article] [PubMed]
- He, X.-Y. & Yang, S.-Y. (1996). Biochemistry, 35, 9625–9630. [DOI] [PubMed]
- Hiraishi, T. & Taguchi, S. (2009). Mini-Rev. Org. Chem. 6, 44–54.
- Kawaguchi, U. & Doi, Y. (1992). Macromolecules, 25, 2324–2329.
- Kim, E.-J., Kim, J., Ahn, J.-W., Kim, Y.-J., Chang, J. H. & Kim, K.-J. (2014). J. Microbiol. Biotechnol. 24, 1636–1643. [DOI] [PubMed]
- Kim, J., Chang, J. H. & Kim, K.-J. (2014). Biochem. Biophys. Res. Commun. 448, 163–168. [DOI] [PubMed]
- Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. (2008). Nature Protoc. 3, 1171–1179. [DOI] [PMC free article] [PubMed]
- Lee, S.-H., Park, S. J., Lee, S. Y. & Hong, S. H. (2008). Appl. Microbiol. Biotechnol. 79, 633–641. [DOI] [PubMed]
- Matsumoto, K., Okei, T., Honma, I., Ooi, T., Aoki, H. & Taguchi, S. (2013). Appl. Microbiol. Biotechnol. 97, 205–210. [DOI] [PubMed]
- Matsumoto, K. & Taguchi, S. (2013). Curr. Opin. Biotechnol. 24, 1054–1060. [DOI] [PubMed]
- Matsumoto, K., Tanaka, Y., Watanabe, T., Motohashi, R., Ikeda, K., Tobitani, K., Yao, M., Tanaka, I. & Taguchi, S. (2013). Appl. Environ. Microbiol. 79, 6134–6139. [DOI] [PMC free article] [PubMed]
- Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
- Oeding, V. & Schlegel, H. G. (1973). Biochem. J. 134, 239–248. [DOI] [PMC free article] [PubMed]
- Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. [DOI] [PubMed]
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. & Ferrin, T. E. (2004). J. Comput. Chem. 25, 1605–1612. [DOI] [PubMed]
- Senior, P. J. & Dawes, E. A. (1973). Biochem. J. 134, 225–238. [DOI] [PMC free article] [PubMed]
- Shen, L., Worrell, E. & Patel, M. (2010). Biofuel. Bioprod. Bioref. 4, 25–40.
- Taguchi, S., Yamada, M., Matsumoto, K., Tajima, K., Satoh, Y., Munekata, M., Ohno, K., Kohda, K., Shimamura, T., Kambe, H. & Obata, S. (2008). Proc. Natl Acad. Sci. USA, 105, 17323–17327. [DOI] [PMC free article] [PubMed]
- Tseng, H.-C., Martin, C. H., Nielsen, D. R. & Prather, K. L. J. (2009). Appl. Environ. Microbiol. 75, 3137–3145. [DOI] [PMC free article] [PubMed]
- Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
- Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A. & Wilson, K. S. (2011). Acta Cryst. D67, 235–242. [DOI] [PMC free article] [PubMed]
- Yamada, M., Matsumoto, L., Shimizu, K., Uramoto, S., Nakai, T., Shozui, F. & Taguchi, S. (2010). Biomacromolecules, 11, 815–819. [DOI] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Figure S1.. DOI: 10.1107/S2053230X18014814/tb5129sup1.pdf